🔴 Neumora Therapeutics is trading 7.6% down in pre-market with no verified catalyst identified

Neumora Therapeutics is trading at $0.43, down 7.64% in October 7 pre-market; no verified company-specific announcement explains the move.

• Shares closed at $0.47, down 10.34% on October 6.
• The latest reported after-hours move was up 5.1% at $0.49, also without an identified company-specific catalyst.
• Broader futures were modestly lower, but available context does not establish a clear market-wide cause.